DEXASPORIN

Post-LOE

neomycin sulfate, polymyxin b sulfate and dexamethasone

Bausch + Lomb

ANDAOPHTHALMICSUSPENSION/DROPS

Approved

Sep 1995

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

DEXASPORIN (neomycin sulfate, polymyxin b sulfate and dexamethasone) by Bausch + Lomb is corticosteroid hormone receptor agonists [moa]. Approved for inflammatory conditions of the palpebral, bulbar conjunctiva, cornea and 6 more indications. First approved in 1995.

Drug data last refreshed 20h ago

Mechanism of Action

Corticosteroid Hormone Receptor Agonists

Pharmacologic Class:

Corticosteroid

Indications (9)

inflammatory conditions of the palpebral bulbar conjunctiva

Worked on DEXASPORIN at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.